Skip to main content

Table 1 Cancers with a clear sex disparity in age-adjusted incidence rates per 100,000 according to SEER explorer incidence data

From: Sex differences in cancer mechanisms

Cancer type

Male average incidence rates

Female average incidence rates

Male:female incidence ratio

Oropharynx and tonsil

4.18

0.86

4.86

Larynx

5.2

1.1

4.73

Esophagus

7.34

1.74

4.22

Urinary Bladder

35.24

8.74

4.03

Mesothelioma

1.58

0.4

3.95

Lip

1.02

0.32

3.19

Liver and intrahepatic bile duct

13.58

4.72

2.88

Tongue

5.22

1.92

2.72

Oral cavity and pharynx

17.02

6.38

2.67

Floor of mouth

0.68

0.3

2.27

Kidney and renal pelvis

22.16

10.92

2.03

Myelodysplastic syndromes

6.2

3.26

1.9

Stomach

10

5.36

1.87

Salivary gland

1.7

1.02

1.67

Leukemia

18.06

10.9

1.66

Melanoma of the skin

28.78

17.46

1.65

Myeloma

8.7

5.58

1.56

Non-Hodgkin lymphoma

23.9

16.22

1.47

Gum and other mouth

1.84

1.28

1.44

Soft tissue including heart

4.14

2.92

1.42

Brain and nervous system

7.52

5.36

1.4

Small intestine

2.74

2.06

1.33

Eye and orbit

1.02

0.78

1.31

Colon and rectum

44.28

33.98

1.3

Lung and bronchus

63.08

48.94

1.29

Pancreas

14.66

11.48

1.28

Hodgkin lymphoma

3

2.38

1.26

Anorectal

1.56

2.22

0.7

Gallbladder

0.9

1.5

0.6

Thyroid

8.04

23.26

0.35

Breast

1.24

127.5

0.01

  1. Incidence rates were calculated by averaging age-adjusted incidence rates per 100,000 from the last 5 years (2012–2016). Male:female ratio was calculated by dividing the male incidence rate by the female incidence rate, both shown in the table. The geometric mean of the male/female incidence ratio is 1.5